CIDOFOVIR
NDC 67457-210, Cidofovir Anhydrous, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-210
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201276
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CIDOFOVIR75 mg/mL
Pharmacologic classes
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-210-05 | 67457021005 | 1 VIAL, GLASS in 1 CARTON (67457-210-05) / 5 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/56541229-8c1a-4550-8951-2415ed08e7e9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-210
Use it
Look up 67457-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.